Characterizing red blood cell age exposure in massive transfusion therapy: the scalar age of blood index (SBI).
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
22
01
2019
revised:
10
04
2019
accepted:
18
04
2019
pubmed:
6
5
2019
medline:
2
6
2020
entrez:
4
5
2019
Statut:
ppublish
Résumé
The mortality of trauma patients requiring massive transfusion to treat hemorrhagic shock approaches 17% at 24 hours and 26% at 30 days. The use of stored RBCs is limited to less than 42 days, so older RBCs are delivered first to rapidly bleeding trauma patients. Patients who receive a greater quantity of older RBCs may have a higher risk for mortality. Characterizing blood age exposure requires accounting for the age of each RBC unit and the quantity of transfused units. To address this challenge, a novel Scalar Age of Blood Index (SBI) that represents the relative distribution of RBCs received is introduced and applied to a secondary analysis of the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) randomized controlled trial (NCT01545232, https://clinicaltrials.gov/ct2/show/NCT01545232). The effect of the SBI is assessed on the primary PROPPR outcome, 24-hour and 30-day mortality. The distributions of blood storage ages successfully maps to a parameter (SBI) that fully defines the blood age curve for each patient. SBI was a significant predictor of 24-hour and 30-day mortality in an adjusted model that had strong predictive ability (odds ratio, 1.15 [1.01-1.29], p = 0.029, C-statistic, 0.81; odds ratio, 1.14 [1.02-1.28], p = 0.019, C-statistic, 0.88, respectively). SBI is a simple scalar metric of blood age that accounts for the relative distribution of RBCs among age categories. Transfusion of older RBCs is associated with 24-hour and 30-day mortality, after adjustment for total units and clinical covariates.
Sections du résumé
BACKGROUND
The mortality of trauma patients requiring massive transfusion to treat hemorrhagic shock approaches 17% at 24 hours and 26% at 30 days. The use of stored RBCs is limited to less than 42 days, so older RBCs are delivered first to rapidly bleeding trauma patients. Patients who receive a greater quantity of older RBCs may have a higher risk for mortality.
METHODS AND MATERIALS
Characterizing blood age exposure requires accounting for the age of each RBC unit and the quantity of transfused units. To address this challenge, a novel Scalar Age of Blood Index (SBI) that represents the relative distribution of RBCs received is introduced and applied to a secondary analysis of the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) randomized controlled trial (NCT01545232, https://clinicaltrials.gov/ct2/show/NCT01545232). The effect of the SBI is assessed on the primary PROPPR outcome, 24-hour and 30-day mortality.
RESULTS
The distributions of blood storage ages successfully maps to a parameter (SBI) that fully defines the blood age curve for each patient. SBI was a significant predictor of 24-hour and 30-day mortality in an adjusted model that had strong predictive ability (odds ratio, 1.15 [1.01-1.29], p = 0.029, C-statistic, 0.81; odds ratio, 1.14 [1.02-1.28], p = 0.019, C-statistic, 0.88, respectively).
CONCLUSION
SBI is a simple scalar metric of blood age that accounts for the relative distribution of RBCs among age categories. Transfusion of older RBCs is associated with 24-hour and 30-day mortality, after adjustment for total units and clinical covariates.
Identifiants
pubmed: 31050809
doi: 10.1111/trf.15334
pmc: PMC6679795
mid: NIHMS1025621
doi:
Banques de données
ClinicalTrials.gov
['NCT01545232']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2699-2708Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM074902
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01HL77864
Pays : United States
Informations de copyright
© 2019 AABB.
Références
Transfus Med Rev. 2015 Apr;29(2):120-6
pubmed: 25573415
Transfusion. 2012 Jun;52(6):1184-95
pubmed: 22188419
N Engl J Med. 2016 Nov 17;375(20):1937-1945
pubmed: 27775503
Biometrics. 2009 Mar;65(1):198-205
pubmed: 18510655
Injury. 2014 May;45(5):819-24
pubmed: 24529718
Cancer Control. 2015 Jan;22(1):26-37
pubmed: 25504276
Ann Thorac Surg. 2019 Mar;107(3):973-980
pubmed: 30342044
J Trauma. 2008 Oct;65(4):794-8
pubmed: 18849793
Ann Emerg Med. 2019 Jun;73(6):650-661
pubmed: 30447946
Injury. 2014 Sep;45(9):1287-95
pubmed: 24996573
Crit Care Nurse. 2017 Apr;37(2):18-30
pubmed: 28365647
Transfusion. 2018 Aug;58(8):1846-1854
pubmed: 29672869
Blood Adv. 2017 Jun 27;1(15):1132-1141
pubmed: 29034365
Lancet Haematol. 2017 Nov;4(11):e544-e552
pubmed: 29021123
N Engl J Med. 2015 Apr 9;372(15):1419-29
pubmed: 25853746
JAMA. 2015 Feb 3;313(5):471-82
pubmed: 25647203
N Engl J Med. 2015 Apr 9;372(15):1410-8
pubmed: 25853745
Biometrics. 1989 Sep;45(3):925-37
pubmed: 2790129
N Engl J Med. 2017 Nov 9;377(19):1858-1867
pubmed: 28952891
Biometrics. 1990 Mar;46(1):33-48
pubmed: 2350571